ID
45135
Beskrivning
Principal Investigator: Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330 Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic alterations that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred within or adjacent to known cancer genes were discovered.
Länk
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330
Nyckelord
Versioner (3)
- 2022-10-08 2022-10-08 - Adrian Schulz
- 2022-10-12 2022-10-12 - Adrian Schulz
- 2022-10-12 2022-10-12 - Adrian Schulz
Rättsinnehavare
Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA
Uppladdad den
8 oktober 2022
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
dbGaP phs000330 The Genomic Complexity of Primary Human Prostate Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
C1512693 (UMLS CUI [1,2])